Eastwood Gillian, Sang Rosemary C, Guerbois Matilde, Taracha Evans L N, Weaver Scott C
Centre for Viral Research, Kenya Medical Research Institute, Nairobi, Kenya.
Institute for Human Infections and Immunity, Center for Tropical Diseases, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas.
Am J Trop Med Hyg. 2017 Nov;97(5):1399-1404. doi: 10.4269/ajtmh.17-0126. Epub 2017 Oct 10.
Chikungunya virus (CHIKV) is a globally emerging pathogen causing debilitating arthralgia and fever in humans. First identified in Tanzania (1953), this mosquito-borne alphavirus received little further attention until a 2004 re-emergence in Kenya from an unknown source. This outbreak subsequently spread to the Indian Ocean, with adaptation for transmission by a new urban vector. Under the hypothesis that sylvatic progenitor cycles of CHIKV exist in Kenya (as reported in West Africa, between non-human primates (NHPs) and arboreal spp. mosquitoes), we pursued evidence of enzootic transmission and human spillover events. We initially screened 252 archived NHP sera from Kenya using plaque reduction neutralization tests. Given an overall CHIKV seroprevalence of 13.1% (marginally higher in western Kenya), we sought more recent NHP samples during 2014 from sites in Kakamega County, sampling wild blue monkeys, olive baboons, and red-tailed monkeys ( = 33). We also sampled 34 yellow baboons near Kwale, coastal Kenya. Overall, CHIKV seropositivity in 2014 was 13.4% (9/67). Antibodies reactive against closely related o'nyong-nyong virus (ONNV) occurred; however, neutralization titers were too low to conclude ONNV exposure. Seroprevalence for the flavivirus dengue was also detected (28%), mostly near Kwale, suggesting possible spillback from humans to baboons. CHIKV antibodies in some juvenile and subadult NHPs suggested recent circulation. We conclude that CHIKV is circulating in western Kenya, despite the 2004 human outbreaks only being reported coastally. Further work to understand the enzootic ecology of CHIKV in east Africa is needed to identify sites of human spillover contact where urban transmission may be initiated.
基孔肯雅病毒(CHIKV)是一种在全球范围内出现的病原体,可导致人类出现使人衰弱的关节痛和发热症状。该病毒于1953年在坦桑尼亚首次被发现,直到2004年在肯尼亚不明原因再次出现之前,这种由蚊子传播的甲病毒很少受到进一步关注。此次疫情随后蔓延至印度洋地区,病毒适应了由一种新的城市媒介进行传播。基于基孔肯雅病毒在肯尼亚存在森林型祖代循环的假设(如在西非报道的,在非人类灵长类动物(NHPs)和树栖蚊种之间),我们探寻了该病毒在动物间传播及人类感染事件的证据。我们最初使用蚀斑减少中和试验对来自肯尼亚的252份存档的非人类灵长类动物血清进行了筛查。鉴于基孔肯雅病毒总体血清阳性率为13.1%(在肯尼亚西部略高),我们在2014年从卡卡梅加县的一些地点采集了更新的非人类灵长类动物样本,对野生蓝猴、橄榄狒狒和红尾猴进行了采样(n = 33)。我们还在肯尼亚沿海的夸勒附近对34只黄狒狒进行了采样。总体而言,2014年基孔肯雅病毒血清阳性率为13.4%(9/67)。检测到了与密切相关的奥尼昂-尼昂病毒(ONNV)发生反应的抗体;然而,中和滴度过低,无法确定是否接触过奥尼昂-尼昂病毒。还检测到了黄病毒登革热的血清阳性率(28%),主要在夸勒附近,这表明可能存在从人类反向传播到狒狒的情况。一些幼年和亚成年非人类灵长类动物体内的基孔肯雅病毒抗体表明该病毒近期有传播。我们得出结论,尽管2004年人类疫情仅在沿海地区有报道,但基孔肯雅病毒正在肯尼亚西部传播。需要开展进一步工作以了解基孔肯雅病毒在东非的动物间生态,从而确定可能引发城市传播的人类感染接触地点。